Editorial
doi: 10.1002/hep.24634.
Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?
- PMID: 21956705
- DOI: 10.1002/hep.24634
Item in Clipboard
Editorial
Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?
Hepatology.
2011 Oct.
No abstract available
Comment on
-
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.Hepatology. 2011 Oct;54(4):1208-16. doi: 10.1002/hep.24491. Epub 2011 Aug 9. Hepatology. 2011. PMID: 21688282 Free PMC article.
Similar articles
-
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.Hepatology. 2003 Aug;38(2):420-7. doi: 10.1053/jhep.2003.50320. Hepatology. 2003. PMID: 12883486
-
Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa. Am J Surg Pathol. 2010. PMID: 20975341
-
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392. Obes Surg. 2006. PMID: 17217634
-
The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.Clin Liver Dis. 2012 Aug;16(3):487-504. doi: 10.1016/j.cld.2012.05.006. Epub 2012 Jun 27. Clin Liver Dis. 2012. PMID: 22824477 Free PMC article. Review.
-
Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.World J Gastroenterol. 2015 Dec 14;21(46):12989-95. doi: 10.3748/wjg.v21.i46.12989. World J Gastroenterol. 2015. PMID: 26675364 Free PMC article. Review.
Cited by
-
Therapy of experimental NASH and fibrosis with galectin inhibitors.PLoS One. 2013 Dec 18;8(12):e83481. doi: 10.1371/journal.pone.0083481. eCollection 2013. PLoS One. 2013. PMID: 24367597 Free PMC article.
-
Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial.PLoS One. 2018 Sep 7;13(9):e0203054. doi: 10.1371/journal.pone.0203054. eCollection 2018. PLoS One. 2018. PMID: 30192782 Free PMC article. Clinical Trial.
-
Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis.PLoS One. 2016 Feb 19;11(2):e0149783. doi: 10.1371/journal.pone.0149783. eCollection 2016. PLoS One. 2016. PMID: 26895034 Free PMC article.
-
Genomic, microbial and environmental standardization in animal experimentation limiting immunological discovery.BMC Immunol. 2020 Sep 2;21(1):50. doi: 10.1186/s12865-020-00380-x. BMC Immunol. 2020. PMID: 32878597 Free PMC article. Review.
-
IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression.Curr Drug Targets. 2015;16(12):1315-23. doi: 10.2174/1389450116666150531153627. Curr Drug Targets. 2015. PMID: 26028039 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical